Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine
Volume 20, Issue 1, December 2024 .
Source: Human Vaccines and Immunotherapeutics - Category: Allergy & Immunology Authors: Hinpetch DaungsupawongViroj Wiwanitkita Private Academic Consultant, Phonhong, Lao People ’s Democratic Republicb Medical College, Saveetha Institute of Medical and Technical Sciences Saveetha University India, Chennai, India Source Type: research
More News: Academia | Allergy & Immunology | Cirrhosis | Covid Vaccine | COVID-19 | India Health | Vaccines